V-Bio Ventures
Christina Takke is the managing partner at V-Bio Ventures. Christina has extensive experience in the biotech industry, having served on the boards of several companies, including Precirix, OCTIMET Oncology NV, OXULAR LIMITED, Confo Therapeutics, and Syndesi Therapeutics. Christina also spent a year as an independent advisor, providing strategic and development advice to various biotech companies. Christina has a proven track record of success, having helped argenx achieve an IPO on Euronext Brussels.
Christina Takke has a PhD in Developmental Biology from the University of Cologne. Christina also has a Bachelor's degree in Developmental Biology from the Institut National de la Recherche Agronomique (INRA) and a Diplom in Biology from the Technische Universität Darmstadt.
Aurelie Nowack - Principal, Katja Rosenkranz - Partner, and Ward Capoen - Partner report to Christina Takke.
This person is not in any offices
V-Bio Ventures
V-Bio Ventures is a venture capital fund that finds, builds, and finances young, innovative companies in the life sciences arena. They invest throughout Europe in start-up and early-stage companies with high growth potential. They focus on technologies that provide transformational improvements in the biopharmaceutical, pharmaceutical, diagnostics, and agricultural sectors.